Oracle insider reports $10.9M proposed stock sale and recent disposals

Rhea-AI Filing Summary

Form 144 for ORCL shows a proposed sale of 33,845 common shares through Fidelity Brokerage on the NYSE with an aggregate market value of $10,869,660.20. The filing lists two recent restricted stock vesting events that produced 11,095 and 22,750 shares, acquired as compensation. It also discloses two sales by the same person, Michael Sicilia, totaling 32,203 shares in the past three months with gross proceeds of $9,160,035.20. The filing includes the total shares outstanding of 2,841,714,000. The filer affirms there is no undisclosed material adverse information and that sales are being reported under Rule 144.

Positive

• Transparent Rule 144 reporting of proposed sale and recent transactions providing investor visibility
• Shares originated from restricted stock vesting, indicating the securities were issued as compensation rather than acquired in open-market purchases

Negative

• Insider sales totaling meaningful proceeds (~$9.16M in past three months and a proposed $10.87M sale) which could be perceived negatively by some investors

Insights

Securities Analyst

TL;DR: Insider sales reported are meaningful in dollar terms but small relative to the company’s outstanding shares, indicating limited market impact.

These entries show a proposed 33,845-share sale valued at about $10.9 million funded by recently vested restricted stock. Recent dispositions by the same individual generated roughly $9.16 million across two trades. As a percentage of the reported 2.84 billion shares outstanding, these volumes are immaterial, suggesting the transactions are unlikely to move the market. The activity is, however, relevant for transparency and insider liquidity analysis.

Corporate Governance Expert

TL;DR: Filing documents standard Rule 144 reporting and shows insider monetization of compensation via vesting and sales.

The filing documents restricted stock vesting followed by proposed sale under Rule 144 and recent completed sales by the same individual. That pattern is consistent with executives or insiders converting compensation into cash. The signer’s attestation that no undisclosed material adverse information exists is standard. Investors monitoring insider behavior will note continuity of sales, but the filing contains no disclosure of any governance or control changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	33845	10869660.20	2841714000	09/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/19/2025	Restricted Stock Vesting	Issuer			11095	09/19/2025	Compensation
Common	09/20/2025	Restricted Stock Vesting	Issuer			22750	09/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Sicilia 2300 Oracle Way Austin TX 78741	Common	08/05/2025	15880	4041142.40
Michael Sicilia 2300 Oracle Way Austin TX 78741	Common	09/16/2025	16323	5118892.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ORCL report?

The form reports a proposed sale of 33,845 common shares via Fidelity on the NYSE with an aggregate market value of $10,869,660.20.

How many shares were acquired through vesting listed in the filing?

The filing lists two restricted stock vesting events totaling 33,845 shares (11,095 and 22,750 shares).

What insider sales occurred in the past three months according to the filing?

Michael Sicilia sold 15,880 shares on 08/05/2025 for $4,041,142.40 and 16,323 shares on 09/16/2025 for $5,118,892.80.

How large are these transactions relative to shares outstanding?

The filing reports 2,841,714,000 shares outstanding; the proposed sale of 33,845 shares is a very small fraction of that total.

Does the filer assert there is undisclosed material information?

Yes. By signing, the person represents they do not know any undisclosed material adverse information about the issuer.